Literature DB >> 30046096

Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features.

Hager Jaouadi1, Lilia Kraoua2, Lilia Chaker3, Alexandre Atkinson4, Valérie Delague4, Nicolas Levy4, Rym Benkhalifa5, Ridha Mrad2, Sonia Abdelhak1, Stéphane Zaffran6.   

Abstract

Pediatric cardiomyopathy is a complex disease with clinical and genetic heterogeneity. Recently, the ALPK3 gene was described as a new hereditary cardiomyopathy gene underlying pediatric cardiomyopathies. Only eight patients carrying mutations in ALPK3 have been reported to date. Here, we report a 3-year-old male patient with both hypertrophic and dilated cardiomyopathy. The patient presented dysmorphic features and skeletal deformities of hands and feet, pectus excavatum, and cleft palate. The genetic investigation was performed by whole-exome sequencing in the patient and his parents. We identified a novel homozygous mutation in ALPK3 (c.1531_1532delAA; p.Lys511Argfs*12). Our work extends the phenotypic spectrum of the ALPK3-associated cardiomyopathy by reporting additional clinical features. This is the first study of a Tunisian patient with mutation in the ALPK3 gene. In conclusion, ALPK3 should be included in the list of genes to be considered in genetic studies for patients affected with pediatric syndromic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30046096     DOI: 10.1038/s10038-018-0492-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  15 in total

Review 1.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 2.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

3.  Cardiomyopathy in α-kinase 3 (ALPK3)-deficient mice.

Authors:  I Van Sligtenhorst; Z-M Ding; Z-Z Shi; R W Read; G Hansen; P Vogel
Journal:  Vet Pathol       Date:  2011-03-25       Impact factor: 2.221

4.  Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.

Authors:  Steven J Kindel; Erin M Miller; Resmi Gupta; Linda H Cripe; Robert B Hinton; Robert L Spicer; Jeffrey A Towbin; Stephanie M Ware
Journal:  J Card Fail       Date:  2012-03-10       Impact factor: 5.712

5.  Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene.

Authors:  K Freeman; C Colon-Rivera; M C Olsson; R L Moore; H D Weinberger; I L Grupp; K L Vikstrom; G Iaccarino; W J Koch; L A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

6.  Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.

Authors:  G M Hecht; H G Klues; W C Roberts; B J Maron
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

7.  The Pediatric Cardiomyopathy Registry: 1995-2007.

Authors:  James D Wilkinson; Lynn A Sleeper; Jorge A Alvarez; Natalya Bublik; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2008-04

8.  Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy.

Authors:  P Spirito; B J Maron
Journal:  J Am Coll Cardiol       Date:  1987-05       Impact factor: 24.094

9.  Pediatric Cardiomyopathy: New Insight Into Potential Disease Mechanisms.

Authors:  Luisa Mestroni; Mary E Sweet; Matthew R G Taylor
Journal:  J Am Coll Cardiol       Date:  2016-02-09       Impact factor: 24.094

10.  ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features.

Authors:  Ahmet Okay Çağlayan; Rabia Gonul Sezer; Hande Kaymakçalan; Ege Ulgen; Taner Yavuz; Jacob F Baranoski; Abdulkadir Bozaykut; Akdes Serin Harmanci; Yalim Yalcin; Mark W Youngblood; Katsuhito Yasuno; Kaya Bilgüvar; Murat Gunel
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-09-01
View more
  5 in total

1.  Atypical ALPK2 kinase is not essential for cardiac development and function.

Authors:  Julius Bogomolovas; Wei Feng; Matthew Daniel Yu; Serena Huang; Lunfeng Zhang; Christa Trexler; Yusu Gu; Simone Spinozzi; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

Review 2.  Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies.

Authors:  Roddy Walsh; Joost A Offerhaus; Rafik Tadros; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2021-09-15       Impact factor: 32.419

3.  Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants.

Authors:  John Jorholt; Yulia Formicheva; Tatyana Vershinina; Artem Kiselev; Alexey Muravyev; Elena Demchenko; Petr Fedotov; Anna Zlotina; Anton Rygkov; Elena Vasichkina; Thomas Sejersen; Anna Kostareva
Journal:  Genes (Basel)       Date:  2020-10-15       Impact factor: 4.096

4.  The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia.

Authors:  Jiaqi Dai; Ke Li; Man Huang; Yang Sun; Hao Liu; Zongzhe Li; Peng Chen; Hong Wang; Dongyang Wu; Yanghui Chen; Lei Xiao; Haoran Wei; Rui Li; Liyuan Peng; Ting Yu; Yan Wang; Dao Wen Wang
Journal:  Front Med (Lausanne)       Date:  2022-06-15

5.  Genome-Wide Association Study Reveals Candidate Genes for Litter Size Traits in Pelibuey Sheep.

Authors:  Wilber Hernández-Montiel; Mario Alberto Martínez-Núñez; Julio Porfirio Ramón-Ugalde; Sergio Iván Román-Ponce; Rene Calderón-Chagoya; Roberto Zamora-Bustillos
Journal:  Animals (Basel)       Date:  2020-03-04       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.